Taiwan FDA registration e48dc0b4a344c4350fa0c8541a04bb7d
"Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized)
TW: "亞培" 百而靈呼吸道融合病毒抗原診斷試劑(未滅菌)
Taiwan·Risk Class 1·Abbott Diagnostics Korea Inc.·Registered Nov 21, 2023 – Nov 21, 2028ActiveRegistration details
- Analysis ID
- e48dc0b4a344c4350fa0c8541a04bb7d
- Customs Code
- DHA09402331400
Company information
- Manufacturer
- Abbott Diagnostics Korea Inc.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- Abbott Rapid Diagnostics Health Corp.
Product details
- Intended Use
- Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3480 呼吸道融合細胞病毒血清試劑
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Nov 21, 2023
- Expiry Date
- Nov 21, 2028
About this record
Access comprehensive regulatory information for "Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number e48dc0b4a344c4350fa0c8541a04bb7d and manufactured by Abbott Diagnostics Korea Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices